Skip to main content

TIVDAK

Generic: tisotumab vedotin

Data may be stale·Apr 23, 2026
NDC
51144-003
RxCUI
2571099
Route
INTRAVENOUS
ICD-10 indication
C53.9

Affordability Check

How much will you actually pay for TIVDAK?

In 30 seconds, see every legitimate way to afford TIVDAK — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About TIVDAK

What is this medication?

Tivdak is a prescription medicine used to treat adults with cervical cancer that has returned or spread to other parts of the body. It is specifically intended for patients whose cancer has progressed during or after treatment with chemotherapy. This medication belongs to a class of drugs known as antibody-drug conjugates, which are designed to deliver medicine directly to specific cancer cells.

The treatment works by targeting a protein called tissue factor that is found on the surface of many cervical cancer cells. Once the medication attaches to these cells, it releases a potent anti-cancer agent into the cell to help destroy it. Patients typically receive this medication as an intravenous infusion administered by a healthcare professional in a clinical setting once every three weeks.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.